{"title":"改善重组生物制品的唾液化以提高治疗效果","authors":"Kah Fai Chan, John S. Y. Goh, Zhiwei Song","doi":"10.4155/PBP.14.44","DOIUrl":null,"url":null,"abstract":"Zhiwei Song Author for correspondence: Bioprocessing Technology Institute, Agency for Science, Technology & Research (A*STAR), 20 Biopolis Way, #06–01 Centros, Singapore 138668, Singapore Tel.: +65 64078844 Fax: +65 64789561 song_zhiwei@bti.a-star.edu.sg “Chinese hamster ovary-gmt4 cells represent an attractive cell line to produce highly sialylated recombinant therapeutics.” Pharmaceutical Editorial","PeriodicalId":90285,"journal":{"name":"Pharmaceutical bioprocessing","volume":"2 1","pages":"363-366"},"PeriodicalIF":0.0000,"publicationDate":"2014-11-19","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.4155/PBP.14.44","citationCount":"3","resultStr":"{\"title\":\"Improving sialylation of recombinant biologics for enhanced therapeutic efficacy\",\"authors\":\"Kah Fai Chan, John S. Y. Goh, Zhiwei Song\",\"doi\":\"10.4155/PBP.14.44\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"Zhiwei Song Author for correspondence: Bioprocessing Technology Institute, Agency for Science, Technology & Research (A*STAR), 20 Biopolis Way, #06–01 Centros, Singapore 138668, Singapore Tel.: +65 64078844 Fax: +65 64789561 song_zhiwei@bti.a-star.edu.sg “Chinese hamster ovary-gmt4 cells represent an attractive cell line to produce highly sialylated recombinant therapeutics.” Pharmaceutical Editorial\",\"PeriodicalId\":90285,\"journal\":{\"name\":\"Pharmaceutical bioprocessing\",\"volume\":\"2 1\",\"pages\":\"363-366\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2014-11-19\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"https://sci-hub-pdf.com/10.4155/PBP.14.44\",\"citationCount\":\"3\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Pharmaceutical bioprocessing\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.4155/PBP.14.44\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Pharmaceutical bioprocessing","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.4155/PBP.14.44","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
Improving sialylation of recombinant biologics for enhanced therapeutic efficacy
Zhiwei Song Author for correspondence: Bioprocessing Technology Institute, Agency for Science, Technology & Research (A*STAR), 20 Biopolis Way, #06–01 Centros, Singapore 138668, Singapore Tel.: +65 64078844 Fax: +65 64789561 song_zhiwei@bti.a-star.edu.sg “Chinese hamster ovary-gmt4 cells represent an attractive cell line to produce highly sialylated recombinant therapeutics.” Pharmaceutical Editorial
京公网安备 11010802042870号
京ICP备2023020795号-1
分享
求助内容：
应助结果提醒方式：
扫码关注我们
